|
Volumn 435, Issue 2-3, 2002, Pages 253-258
|
Weekly pulse therapy of methotrexate improves survival compared with its daily administration in MRL/lpr mice
|
Author keywords
Methotrexate; MRL lpr mouse; Myelosuppression; Pulse therapy weekly; Survival
|
Indexed keywords
DNA ANTIBODY;
METHOTREXATE;
RHEUMATOID FACTOR;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTHROPATHY;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG PULSE THERAPY;
DRUG TOXICITY;
ERYTHROCYTE COUNT;
KIDNEY DISEASE;
LEUKOCYTE COUNT;
LYMPHADENOPATHY;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PRIORITY JOURNAL;
PROTEINURIA;
RHEUMATOID ARTHRITIS;
SURVIVAL RATE;
ANIMALS;
ANTIRHEUMATIC AGENTS;
AUTOANTIBODIES;
AUTOIMMUNITY;
BLOOD CELL COUNT;
BODY WEIGHT;
GLOMERULONEPHRITIS;
KIDNEY FUNCTION TESTS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LYMPHATIC DISEASES;
MALE;
METHOTREXATE;
MICE;
MICE, INBRED MRL LPR;
PROTEINURIA;
SURVIVAL ANALYSIS;
UREA;
|
EID: 0037169166
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)01555-2 Document Type: Article |
Times cited : (8)
|
References (18)
|